Formed in late 2004, Codon Devices is still a relative newcomer to the field. But that hasn’t stopped it from shooting to be a leader in the gene synthesis industry — and with a recent deal with ag biotech Agrivida under its belt, the startup is certainly taking steps toward that goal.

With co-founders including George Church, Drew Endy, Jay Keasling, and Joseph Jacobson, it’s no wonder Codon already has a bevy of customers and has also played a critical role in trying to shape the education and regulatory environment surrounding gene synthesis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.